偶然分枝杆菌偶然生物变种以及龟分枝杆菌两个亚群对亚胺培南、头孢美唑、头孢西丁和阿莫西林-克拉维酸的敏感性。
Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.
作者信息
Wallace R J, Brown B A, Onyi G O
机构信息
Department of Microbiology, University of Texas Health Center, Tyler 75710.
出版信息
Antimicrob Agents Chemother. 1991 Apr;35(4):773-5. doi: 10.1128/AAC.35.4.773.
Abstract
MICs of imipenem, cefoxitin, cefmetazole, and amoxicillin-clavulanic acid were determined against 100 strains of Mycobacterium fortuitum and 200 strains of Mycobacterium chelonae. Imipenem and cefmetazole were more active against M. fortuitum than cefoxitin was, and imipenem (which inhibited 39% of strains at 8 micrograms/ml) was the only beta-lactam active against M. chelonae subsp. chelonae.
摘要
测定了亚胺培南、头孢西丁、头孢美唑和阿莫西林-克拉维酸对100株偶然分枝杆菌和200株龟分枝杆菌的最低抑菌浓度（MIC）。亚胺培南和头孢美唑对偶然分枝杆菌的活性比头孢西丁更强，并且亚胺培南（在8微克/毫升时可抑制39%的菌株）是唯一对龟分枝杆菌龟亚种有活性的β-内酰胺类药物。
相似文献
1
Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.偶然分枝杆菌偶然生物变种以及龟分枝杆菌两个亚群对亚胺培南、头孢美唑、头孢西丁和阿莫西林-克拉维酸的敏感性。
Antimicrob Agents Chemother. 1991 Apr;35(4):773-5. doi: 10.1128/AAC.35.4.773.
2
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.来自美国28个中心的320株非脆弱拟杆菌属拟杆菌分离株和129株梭杆菌属细菌的β-内酰胺酶产生情况以及对阿莫西林、阿莫西林-克拉维酸、替卡西林、替卡西林-克拉维酸、头孢西丁、亚胺培南和甲硝唑的敏感性。
Antimicrob Agents Chemother. 1990 Aug;34(8):1546-50. doi: 10.1128/AAC.34.8.1546.
3
Susceptibilities of nontuberculosis mycobacterial species to amoxicillin-clavulanic acid alone and in combination with antimycobacterial agents.非结核分枝杆菌对单独使用阿莫西林-克拉维酸以及与抗分枝杆菌药物联合使用的敏感性。
Antimicrob Agents Chemother. 1995 Jul;39(7):1454-7. doi: 10.1128/AAC.39.7.1454.
4
Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole.非脆弱拟杆菌和梭杆菌对阿莫西林、阿莫西林/克拉维酸、替卡西林、替卡西林/克拉维酸、头孢西丁、亚胺培南和甲硝唑的敏感性。
Eur J Clin Microbiol Infect Dis. 1990 Jun;9(6):417-21. doi: 10.1007/BF01979473.
5
Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.来自美国33个中心的737株脆弱拟杆菌属微生物的β-内酰胺酶产生情况、β-内酰胺敏感性以及与克拉维酸协同作用的耐药性
J Antimicrob Chemother. 1990 Sep;26(3):361-70. doi: 10.1093/jac/26.3.361.
6
In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid.偶然分枝杆菌对阿莫西林或头孢噻吩与克拉维酸联合用药的体外敏感性。
Antimicrob Agents Chemother. 1983 Jun;23(6):935-7. doi: 10.1128/AAC.23.6.935.
7
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.脓肿分枝杆菌、龟分枝杆菌和偶发分枝杆菌肉汤微量稀释法药敏试验结果的多中心可重复性。
J Clin Microbiol. 1999 Jun;37(6):1676-82. doi: 10.1128/JCM.37.6.1676-1682.1999.
8
Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.亚胺培南与β-内酰胺类药物联合舒巴坦和克拉维酸在产β-内酰胺酶的脆弱拟杆菌菌株中的活性比较。
J Hyg Epidemiol Microbiol Immunol. 1991;35(2):189-97.
9
In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.偶然分枝杆菌对N-甲酰亚胺基硫霉素及几种头孢霉素的体外敏感性
Antimicrob Agents Chemother. 1982 Dec;22(6):1079-81. doi: 10.1128/AAC.22.6.1079.
10
In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin.结核分枝杆菌、偶然分枝杆菌和龟分枝杆菌对阿莫西林克拉维酸钾的体外敏感性
Eur J Clin Microbiol. 1986 Aug;5(4):453-4. doi: 10.1007/BF02075706.
引用本文的文献
1
A Case Report of Wound Infection Caused by .由……引起的伤口感染病例报告
Infect Drug Resist. 2025 Jun 27;18:3187-3197. doi: 10.2147/IDR.S513994. eCollection 2025.
2
Mab2780c, a TetV-like efflux pump, confers high-level spectinomycin resistance in mycobacterium abscessus.Mab2780c 是一种 TetV 样外排泵，可赋予脓肿分枝杆菌高水平的大观霉素耐药性。
Tuberculosis (Edinb). 2023 Jan;138:102295. doi: 10.1016/j.tube.2022.102295. Epub 2022 Dec 22.
3
Central nervous system infection caused by : A case report.由……引起的中枢神经系统感染：一例报告。
Front Neurol. 2022 Sep 1;13:908086. doi: 10.3389/fneur.2022.908086. eCollection 2022.
4
Mycobacterium abscessus HelR interacts with RNA polymerase to confer intrinsic rifamycin resistance.耻垢分枝杆菌HelR 与 RNA 聚合酶相互作用赋予固有利福霉素耐药性。
Mol Cell. 2022 Sep 1;82(17):3166-3177.e5. doi: 10.1016/j.molcel.2022.06.034. Epub 2022 Jul 28.
5
Antibiotic Susceptibility of Mycobacteria Isolated from Ornamental Fish.从观赏鱼中分离出的分枝杆菌的抗生素敏感性
J Vet Res. 2022 Mar 25;66(1):69-76. doi: 10.2478/jvetres-2022-0011. eCollection 2022 Mar.
6
A first case report of nasopharyngeal Mycobacterium abscessus subspecies massiliense infection.首例鼻咽部脓肿分枝杆菌亚种马萨利ensis 感染的病例报告。
Eur J Med Res. 2021 Sep 18;26(1):109. doi: 10.1186/s40001-021-00578-8.
7
Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease.非结核分枝杆菌病的诊断与治疗方法
J Clin Tuberc Other Mycobact Dis. 2021 May 8;24:100244. doi: 10.1016/j.jctube.2021.100244. eCollection 2021 Aug.
8
Case of atypical cutaneous infection in patient of systemic lupus erythematosus after cyclophosphamide therapy.系统性红斑狼疮患者环磷酰胺治疗后出现非典型皮肤感染病例。
BMJ Case Rep. 2019 Dec 8;12(12):e231930. doi: 10.1136/bcr-2019-231930.
9
Peritoneal dialysis-associated infection caused by Mycobacterium abscessus: a case report.腹腔透析相关性脓肿分枝杆菌感染：一例报告。
BMC Nephrol. 2018 Nov 29;19(1):341. doi: 10.1186/s12882-018-1148-2.
10
High Levels of Intrinsic Tetracycline Resistance in Mycobacterium abscessus Are Conferred by a Tetracycline-Modifying Monooxygenase.高水平的固有四环素耐药性在脓肿分枝杆菌中是由四环素修饰单加氧酶赋予的。
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00119-18. Print 2018 Jun.
本文引用的文献
1
Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.阿米卡星和多西环素治疗偶然分枝杆菌和龟分枝杆菌感染的临床效用。
Rev Infect Dis. 1981 Sep-Oct;3(5):1068-74. doi: 10.1093/clinids/3.5.1068.
2
In vitro susceptibility of Mycobacterium fortuitum to cefoxitin.偶然分枝杆菌对头孢西丁的体外敏感性
Antimicrob Agents Chemother. 1981 Jan;19(1):205-7. doi: 10.1128/AAC.19.1.205.
3
In vitro susceptibility of mycobacterium fortuitum and mycobacterium chelonei to cefoxitin.偶然分枝杆菌和龟分枝杆菌对头孢西丁的体外敏感性
Tubercle. 1982 Jun;63(2):125-7. doi: 10.1016/s0041-3879(82)80049-4.
4
In vitro susceptibility of mycobacteria species other than Mycobacterium tuberculosis to amikacin, cephalosporins and cefoxitin.
Chemotherapy. 1982;28(1):1-5. doi: 10.1159/000238053.
5
Identification of clinically significant Mycobacterium fortuitum complex isolates.具有临床意义的偶然分枝杆菌复合群菌株的鉴定。
J Clin Microbiol. 1981 Dec;14(6):686-91. doi: 10.1128/jcm.14.6.686-691.1981.
6
In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.偶然分枝杆菌对N-甲酰亚胺基硫霉素及几种头孢霉素的体外敏感性
Antimicrob Agents Chemother. 1982 Dec;22(6):1079-81. doi: 10.1128/AAC.22.6.1079.
7
Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.快速生长分枝杆菌：采用肉汤微量稀释法检测对34种抗菌药物的敏感性
Antimicrob Agents Chemother. 1982 Aug;22(2):186-92. doi: 10.1128/AAC.22.2.186.
8
In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid.偶然分枝杆菌对阿莫西林或头孢噻吩与克拉维酸联合用药的体外敏感性。
Antimicrob Agents Chemother. 1983 Jun;23(6):935-7. doi: 10.1128/AAC.23.6.935.
9
Spectrum of disease due to rapidly growing mycobacteria.快速生长分枝杆菌所致疾病谱
Rev Infect Dis. 1983 Jul-Aug;5(4):657-79. doi: 10.1093/clinids/5.4.657.
10
Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei.使用多粘菌素和阿米卡星进行纸片扩散试验以区分偶然分枝杆菌和龟分枝杆菌。
J Clin Microbiol. 1982 Dec;16(6):1003-6. doi: 10.1128/jcm.16.6.1003-1006.1982.
Zotero 插件